ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

NAOV NanoVibronix Inc

0.758499
0.0085 (1.13%)
Apr 26 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 15,202
Bid Price 0.745
Ask Price 1.52
News -
Day High 0.7999

Low
0.70

52 Week Range

High
4.34

Day Low 0.75
Share Name Share Symbol Market Stock Type
NanoVibronix Inc NAOV NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.0085 1.13% 0.758499 23:00:05
Open Price Low Price High Price Close Price Previous Close
0.765 0.75 0.7999 0.758499 0.75
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
96 15,202 US$ 0.7599859 US$ 11,553 - 0.70 - 4.34
Last Trade Type Quantity Price Currency
16:38:16 75 US$ 0.76 USD

NanoVibronix Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
1.56M 2.05M - 2.28M -3.71M -1.81 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

NanoVibronix News

Date Time Source News Article
4/09/202407:30Business WireNanoVibronix Issues Letter to Stockholders
3/28/202407:30Business WireNanoVibronix Signs Agreement for Research and Development of..
2/26/202416:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/23/202418:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/23/202418:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/23/202418:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/23/202418:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/14/202414:45Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial..
1/17/202415:31Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting..
1/17/202415:30Edgar (US Regulatory)Form 8-K - Current report
12/11/202315:30Edgar (US Regulatory)Form 8-K - Current report
12/06/202315:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No NAOV Message Board. Create One! See More Posts on NAOV Message Board See More Message Board Posts

Historical NAOV Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.740.80250.740.772310215,3640.01852.50%
1 Month0.87320.93250.700.82572420,876-0.1147-13.14%
3 Months0.92281.520.701.0656,077-0.1643-17.80%
6 Months0.841.54990.701.0580,564-0.0815-9.70%
1 Year3.164.340.702.31433,838-2.40-76.00%
3 Years19.80283.800.7043.202,600,476-19.04-96.17%
5 Years68.87695.000.7037.552,194,381-68.12-98.90%

NanoVibronix Description

NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low frequency, low intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients as well as through distributor agreements.

Your Recent History

Delayed Upgrade Clock